Skip to main content

GVP - Product- or Population-Specific Considerations I: Vaccines for prophylaxis against infectious diseases

2020-01-23
GVP - Product- or Population-Specific Considerations I: Vaccines for prophylaxis against infectious diseases
Guide
Has the page content helped you?

Guideline on Pharmacovigilance for Veterinary Products

2020-01-21
Guideline on Pharmacovigilance for Veterinary Products
Guide
Has the page content helped you?

DMFs List Received​

2024-05-12
DMFs List Received​
Has the page content helped you?

Classification Table of Violations and Fines Prescribed in the Veterinary Products Law in Gulf Cooperation Council (GCC) Countries

2018-02-11
Classification Table of Violations and Fines Prescribed in the Veterinary Products Law in Gulf Cooperation Council (GCC) Countries
List
Has the page content helped you?

Contingency plans to reduce the risks of using formula (EXJADE ® (Deferasirox

Contingency plans to reduce the risks of using formula (EXJADE ® (Deferasirox
Publication Date
Applying Date

Circular Clinical Trial on drugs

Circular Clinical Trial on drugs
Publication Date
Applying Date
2012-12-05

SFDA requirements for labeling and Packaging for investigational medicinal products (IMP)

SFDA requirements for labeling and Packaging for investigational medicinal products (IMP)
Publication Date
Applying Date
2012-12-05

Increased Risk of Death Associated With Use of Tigecycline) Tygacil®)

Increased Risk of Death Associated With Use of Tigecycline) Tygacil®)
Publication Date
Applying Date
2013-12-09

Cough and cold medications should not be used for infants and children <6 years of age

Cough and cold medications should not be used for infants and children <6 years of age
Publication Date
Applying Date
2013-12-09

Safety warning : Peripheral neuropathy and telbivudine

Safety warning : Peripheral neuropathy and telbivudine
Publication Date
Applying Date
2013-12-09
Subscribe to Drugs